Key facts
- Notable investors include Innovation Authority, Deep Future, embARC Ventures (Tel Aviv).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nuri Braintech
- ·The full record, as it builds
Funding rounds
No funding rounds for Nuri Braintech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nuri Braintech
Developer of emotional brain-computer interface technology intended to treat severe PTSD through precision neuromodulation. The company's emotional brain-computer interface reduces fear responses through deep brain stimulation and retains memory without the associated emotional distress, enabling patients with severe PTSD to experience lasting relief by transforming traumatic memories into fear-free recollections through advanced neurotechnology.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2024
- Employees
- 5
- Website
- brainvalue.health/
- Ownership
- Privately Held (backing)
Nuri Braintech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nuri Braintech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nuri Braintech in its N-PORT filings yet. We sweep new filings monthly.